PR
INSM icon

PSP Research’s Insmed INSM Stock Holding History

PSP Research’s Portfolio INSM Stock Details INSM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-3,049
Closed -$531K – 90
2025
Q4 		$531K Buy
+3,049
New +$556K 0.46% 41

Other funds holding INSM

JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
DGM
Darwin Global Management St. Helier, Jersey $3.76B AUM 342.13% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
BBA
Baker Bros. Advisors New York $20B AUM 154.41% 1-Year Est. Return
Artisan Partners
Artisan Partners Milwaukee, Wisconsin $63.1B AUM 35.51% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return

PSP Research's INSM Position: Q1 2026 in Review

PSP Research sold out of Insmed (INSM) in Q1 2026, closing a stake of 3,049 shares — an estimated $531K sold.

PSP Research first reported a position in INSM in Q4 2025 and held it in 1 quarter. The position peaked at $531K in Q4 2025. 674 funds tracked by Wall St. Rank hold INSM as of Q1 2026.

  • PSP Research reported no remaining Insmed position as of Q1 2026 after selling out during the quarter.
  • PSP Research sold 3,049 Insmed shares in Q1 2026, an estimated $531K.
  • PSP Research first reported a position in Insmed in Q4 2025 and held it in 1 quarter.
  • PSP Research's Insmed position peaked at $531K in Q4 2025.
  • 674 funds tracked by Wall St. Rank held Insmed as of Q1 2026.

Based on PSP Research's 13F filing for Q1 2026, filed 17 Apr 2026.